scholarly journals 011 A new molecular mechanism for familial dilated cardiomyopathy based on studies with intact mutant transgenic mouse and human explanted heart muscle

Heart ◽  
2010 ◽  
Vol 96 (4) ◽  
pp. e4-e4
Author(s):  
M. Memo ◽  
A. E. Messer ◽  
W. Song ◽  
S. B. Marston
2009 ◽  
Vol 2 (5) ◽  
pp. 456-464 ◽  
Author(s):  
Emma C. Dyer ◽  
Adam M. Jacques ◽  
Anita C. Hoskins ◽  
Douglas G. Ward ◽  
Clare E. Gallon ◽  
...  

2010 ◽  
Vol 49 (3) ◽  
pp. 380-389 ◽  
Author(s):  
Weihua Song ◽  
Emma Dyer ◽  
Daniel Stuckey ◽  
Man-Ching Leung ◽  
Massimiliano Memo ◽  
...  

2019 ◽  
Vol 5 (9) ◽  
pp. eaax2066 ◽  
Author(s):  
Rebecca C. Ahrens-Nicklas ◽  
Christopher T. Pappas ◽  
Gerrie P. Farman ◽  
Rachel M. Mayfield ◽  
Tania M. Larrinaga ◽  
...  

Neonatal heart failure is a rare, poorly-understood presentation of familial dilated cardiomyopathy (DCM). Exome sequencing in a neonate with severe DCM revealed a homozygous nonsense variant in leiomodin 2 (LMOD2, p.Trp398*). Leiomodins (Lmods) are actin-binding proteins that regulate actin filament assembly. While disease-causing mutations in smooth (LMOD1) and skeletal (LMOD3) muscle isoforms have been described, the cardiac (LMOD2) isoform has not been previously associated with human disease. Like our patient, Lmod2-null mice have severe early-onset DCM and die before weaning. The infant’s explanted heart showed extraordinarily short thin filaments with isolated cardiomyocytes displaying a large reduction in maximum calcium-activated force production. The lack of extracardiac symptoms in Lmod2-null mice, and remarkable morphological and functional similarities between the patient and mouse model informed the decision to pursue cardiac transplantation in the patient. To our knowledge, this is the first report of aberrant cardiac thin filament assembly associated with human cardiomyopathy.


2002 ◽  
Vol 39 ◽  
pp. 149
Author(s):  
Andrea Di Lenarda ◽  
Elisa Carniel ◽  
Gastone Sabbadini ◽  
Mauro Driussi ◽  
Serena Rakar ◽  
...  

Author(s):  
P Hutsteiner ◽  
N Jenewein ◽  
J Christ ◽  
O Ortmann ◽  
U Germer

Circulation ◽  
1995 ◽  
Vol 92 (12) ◽  
pp. 3387-3389 ◽  
Author(s):  
Jean-Bernard Durand ◽  
Linda L. Bachinski ◽  
Lisa C. Bieling ◽  
Grazyna Z. Czernuszewicz ◽  
Antoine B. Abchee ◽  
...  

2021 ◽  
Vol 11 (3) ◽  
pp. 122-128
Author(s):  
Priya Bhardwaj ◽  
Christoffer Rasmus Vissing ◽  
Niels Kjær Stampe ◽  
Kasper Rossing ◽  
Alex Hørby Christensen ◽  
...  

Background: AARS2 encodes the mitochondrial protein alanyl-tRNA synthetase 2 (MT-AlaRS), an important enzyme in oxidative phosphorylation. Variants in AARS2 have previously been associated with infantile cardiomyopathy. Case summary: A 4-year-old girl died of infantile-onset dilated cardiomyopathy (DCM) in 1996. Fifteen years later, her 21-year-old brother was diagnosed with DCM and ultimately underwent heart transplantation. Initial sequencing of 15 genes discovered no pathogenic variants in the brother at the time of his diagnosis. However, 9 years later re-screening in an updated screening panel of 129 genes identified a homozygous AARS2 (c.1774C > T) variant. Sanger sequencing of the deceased girl confirmed her to be homozygous for the AARS2 variant, while both parents and a third sibling were all found to be unaffected heterozygous carriers of the AARS2 variant. Discussion: This report underlines the importance of repeated and extended genetic screening of elusive families with suspected hereditary cardiomyopathies, as our knowledge of disease-causing mutations continuously grows. Although identification of the genetic etiology in the reported family would not have changed the clinical management, the genetic finding allows genetic counselling and holds substantial value in identifying at-risk relatives.


Sign in / Sign up

Export Citation Format

Share Document